Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
David Strayer
(section)
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Notable studies== *1994, [[Ampligen]] inhibits human [[Human herpesvirus 6|herpesvirus-6]] in vitro<ref name="Ablashi, 1994"/> [https://www.ncbi.nlm.nih.gov/pubmed/7893986 (Abstract)] *1994, A controlled clinical trial with a specifically configured RNA drug, [[Ampligen|poly(I).poly(C12U)]], in [[chronic fatigue syndrome]]<ref name="Strayer,1994"/> [http://www.ncbi.nlm.nih.gov/pubmed/8148460 (Abstract)] *1995, Long Term Improvements in Patients with [[Chronic Fatigue Syndrome]] Treated with [[Ampligen]]<ref name="Strayer,1995"/> [https://scholars.opb.msu.edu/en/publications/long-term-improvements-in-patients-with-chronic-fatigue-syndrome- (Abstract)] *2001, Assessment of Functional Impairment by [[Two-day cardiopulmonary exercise test|Cardiopulmonary Exercise Testing]] in Patients with [[Chronic Fatigue Syndrome]]<ref name="VanNess, 2001"/> [http://www.tandfonline.com/doi/abs/10.1300/J092v08n03_09 (Abstract)] *2005, [[Exercise]] capacity and immune function in male and female patients with [[Chronic Fatigue Syndrome]]<ref name="Snell, 2005"/> [[http://iv.iiarjournals.org/content/19/2/387.full.pdf (Full Text)] *2007, Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine<ref> Takeshi Ichinohe, Shin-ichi Tamura, Akira Kawaguchi, Ai Ninomiya, Masaki Imai, Shigeyuki Itamura, Takato Odagiri, Masato Tashiro, Hidehiro Takahashi, Hirofumi Sawa, William M. Mitchell, David R. Strayer, William A. Carter, Joe Chiba, Takeshi Kurata, Tetsutaro Sata and Hideki Hasegawa. The Journal of Infectious Diseases, Vol. 196, No. 9 (Nov. 1, 2007), pp. 1313-1320. Url: http://www.jstor.org/stable/30086851</ref> [http://www.jstor.org/stable/30086851?seq=1#page_scan_tab_contents (Abstract)] *2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist [[rintatolimod]] in severe cases of [[chronic fatigue syndrome]]<ref name="Strayer, 2012"/> [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0031334 (Full Text)] *2015, Low [[Natural killer cell|NK Cell]] Activity in [[Chronic Fatigue Syndrome]] (CFS) and Relationship to Symptom Severity<ref name="strayer2015"/> [https://www.omicsonline.org/open-access/low-nk-cell-activity-in-chronic-fatigue-syndrome-cfs-and-relationship-to-symptom-severity-2155-9899-1000348.pdf (Full Text)] *2015, [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)]]: Characteristics of Responders to [[Rintatolimod]]<ref name="Strayer, 8Aug2015"/> [https://sciforschenonline.org/journals/drug/article-data/JDRD-1-103/JDRD-1-103.pdf (Full Text)]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs